Pfenex Inc. has entered into a non-exclusive strategic partnership with SAFC, a unit of the Sigma-Aldrich Corp., under which Pfenex will engineer production strains and processes for SAFC’s contract manufacturing customers. The developed processes will then be transferred to SAFC’s fermentation facility in Jerusalem for cGMP production. The two companies also plan to work together to combine Pfenex’s Reagent Proteins product offerings in the area of vaccine components with SAFC’s expertise and f...